Anchor Bay Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Anchor Bay Capital's PFE Position: Q3 2026 in Review
Anchor Bay Capital increased its Pfizer (PFE) stake by 21% in Q3 2026, buying an estimated $111K and bringing the position to 24,132 shares worth $721K. The position accounts for 0.38% of the portfolio, ranked #69.
Anchor Bay Capital first reported a position in PFE in Q2 2026 and has held it in 2 quarters since. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Anchor Bay Capital held 24,132 shares of Pfizer worth $721K as of Q3 2026.
- Anchor Bay Capital bought 4,167 Pfizer shares in Q3 2026, an estimated $111K.
- Pfizer made up 0.38% of Anchor Bay Capital's portfolio in Q3 2026, its #69 holding.
- Anchor Bay Capital first reported a position in Pfizer in Q2 2026 and has held it in 2 quarters since.
- 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Anchor Bay Capital's 13F filing for Q3 2026, filed 13 Nov 2026.